ACUTE MACULAR NEURORETINOPATHY FOLLOWING SARS-CoV-2 VACCINATION.

Autor:	Afonso MG; Centro Hospitalar Universitário do Porto- Hospital de Santo António, Oporto, Portugal; and., Marques JH; Centro Hospitalar Universitário do Porto- Hospital de Santo António, Oporto, Portugal; and., Monteiro S; From the Hospital Santa Maria Maior, Barcelos, Portugal., Lume M; Centro Hospitalar Universitário do Porto- Hospital de Santo António, Oporto, Portugal; and., Abreu AC; Centro Hospitalar Universitário do Porto- Hospital de Santo António, Oporto, Portugal; and., Maia S; Centro Hospitalar Universitário do Porto- Hospital de Santo António, Oporto, Portugal; and.
Jazyk:	angličtina
Zdroj:	Retinal cases & brief reports [Retin Cases Brief Rep] 2023 Jul 01; Vol. 17 (4), pp. 438-440.
DOI:	10.1097/ICB.0000000000001222
Abstrakt:	Purpose: To report a case of acute macular neuroretinopathy (AMN) following SARS-CoV-2 vaccination. Methods: Case report. Results: An otherwise healthy 28-year-old white woman presented to an ophthalmology department with complaints of black paracentral vision scotomata on both eyes that appeared 2 days after receiving the first dose of Vaxzevria vaccine. Fundus examination revealed bilateral red brown petaloid lesions around the fovea. On spectral domain optical coherence tomography, a hyperreflective plaque between the outer plexiform and outer nuclear layers along with disruption of ellipsoid zone/interdigitation zone was observed. A diagnosis of AMN was made. Conclusion: AMN may be an extremely rare adverse event of SARS-COV-2 vaccination, especially in patients with other risk factors. Synopsis: An otherwise healthy 28-year-old white woman was diagnosed with AMN 2 days after SARS-CoV-2 vaccination.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu